Literature DB >> 15185295

Susceptibility of murine periportal hepatocytes to hypoxia-reoxygenation: role for NO and Kupffer cell-derived oxidants.

Hisashi Taniai1, Ian N Hines, Sulaiman Bharwani, Ronald E Maloney, Yuji Nimura, Bifeng Gao, Sonia C Flores, Joe M McCord, Matthew B Grisham, Tak Yee Aw.   

Abstract

Ischemia/reperfusion (I/R) is an important problem in liver resection and transplantation that is associated with hepatocellular dysfunction and injury. This study was designed to investigate whether a difference in hepatocyte susceptibility occurs in the periportal (PP) and/or perivenous (PV) zones in response to hypoxia/reoxygenation (H/R), and to delineate the mechanisms underlying this susceptibility. H/R was induced in an in situ perfused mouse liver model with deoxygenated Krebs-Henseleit buffer followed by oxygenated buffer. Selective destruction of PP or PV sites was achieved by digitonin perfusion into the portal or inferior vena cava, and was confirmed by histological evaluations and zone-specific enzymes. Hepatocellular injury was assessed by alanine aminotransferase (ALT) release. In whole liver, H/R significantly increased perfusate ALT. H/R of PP-enriched zones caused ALT release that was similar to that of whole liver (80 + 10 vs. 70 + 12 U/mg protein), consistent with significant PP hepatocyte injury. Minimal ALT release occurred in PV zones (10 + 5 U/mg protein). Administration of N-acetyl L-cysteine or a chimeric superoxide dismutase (SOD)-SOD2/3, a genetically engineered SOD-abrogated ALT release in H/R-perfused PP zones, implicating a role for superoxide (O(2) (-)). This elevated ALT release was attenuated by gadolinium chloride pretreatment, indicating that Kupffer cells are the O(2) (-) source. Enzymatic inhibition of cellular nitric oxide synthase (NOS) or genetic depletion of endothelial nitric oxide synthase (eNOS) aggravated hypoxia injury while exogenous NO and inducible nitric oxide synthase (iNOS) deficiency abolished reoxygenation injury. In conclusion, PP hepatocytes are more vulnerable to H/R; this injury is mediated directly or indirectly by Kupffer cell derived O(2) (-) and is limited by eNOS-derived NO.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185295     DOI: 10.1002/hep.20217

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: Role of vasodilatory and innate immunity pathways.

Authors:  T P Theruvath; Z Zhong; R T Currin; V K Ramshesh; J J Lemasters
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

2.  Vascular biology and pathobiology of the liver: Report of a single-topic symposium.

Authors:  Yasuko Iwakiri; Matthew Grisham; Vijay Shah
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

3.  How to protect liver graft with nitric oxide.

Authors:  Hassen Ben Abdennebi; Mohamed Amine Zaoualí; Izabel Alfany-Fernandez; Donia Tabka; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

4.  Novel in vitro model for studying hepatic ischemia-reperfusion injury using liver cubes.

Authors:  Bernard J DuBray; Kendra D Conzen; Gundumi A Upadhya; Parvathi Balachandran; Jianluo Jia; Brett L Knolhoff; David H Alpers; Thallachallour Mohanakumar; William C Chapman; Christopher D Anderson
Journal:  Surgery       Date:  2012-06-13       Impact factor: 3.982

5.  Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.

Authors:  Tommy R Gardner; Qingling Chen; Yijun Jin; Maureen N Ajuebor
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

6.  Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats.

Authors:  Ercan Gedik; Sadullah Girgin; Hayrettin Ozturk; Basra-Deniz Obay; Hulya Ozturk; Huseyin Buyukbayram
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

7.  Effect of notoginsenoside R1 on hepatic microcirculation disturbance induced by gut ischemia and reperfusion.

Authors:  Wei-Xing Chen; Fang Wang; Yu-Ying Liu; Qing-Jiang Zeng; Kai Sun; Xin Xue; Xiang Li; Ji-Ying Yang; Li-Hua An; Bai-He Hu; Jin-Hui Yang; Chuan-She Wang; Zhi-Xin Li; Lian-Yi Liu; Yan Li; Jun Zheng; Fu-Long Liao; Dong Han; Jing-Yu Fan; Jing-Yan Han
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 8.  Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury.

Authors:  Yuta Abe; Ian Hines; Gazi Zibari; Matthew B Grisham
Journal:  Arch Biochem Biophys       Date:  2008-10-12       Impact factor: 4.013

Review 9.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

10.  Variable responses of small and large human hepatocytes to hypoxia and hypoxia/reoxygenation (H-R).

Authors:  Ricky H Bhogal; Christopher J Weston; Stuart M Curbishley; Anand N Bhatt; David H Adams; Simon C Afford
Journal:  FEBS Lett       Date:  2011-02-25       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.